Harte Hanks Inc (HHS)
NASDAQIndustrialsSpecialty Business ServicesSnapshot 2026-09-09
$4.220.00%
Close 2026-09-09 · 1-day change
NASDAQIndustrialsSpecialty Business ServicesSnapshot 2026-09-09
Broken: Primary pillar broken — Return to profitability: TTM net margin -3.7% vs positive target; TTM OCF -$0.6M vs positive target.
Harte Hanks aims to deepen customer relationships to drive growth. The company is working to improve its financial health after recent losses. Its valuation is cheap compared to peers, offering upside if execution improves.
Revenue is expected to decline about 14% next year. The company is loss-making with negative free cash flow. Recent earnings misses and management changes raise doubts about recovery.
The market prices in about -14% revenue decline and expects continued weakness. Our fair value at $9.04 reflects this cautious outlook, with limited upside unless turnaround succeeds.
Breaks if: progress score remains below 40% next 4 quarters
Focus on aligning around priority sectors and combining customer experience expertise with technology to drive profitable growth.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround opportunity. HHS is currently struggling with earnings quality and recent financial performance, but management is focused on improving customer relationships and achieving positive EBITDA.
The market appears to have priced in a low valuation compared to peers, reflecting a justified stance given the company's loss-making status. There is an expectations gap, indicating that investors may anticipate further challenges ahead.
Fundamentals are likely to remain under pressure in the near term due to a high probability of an earnings miss. Management's focus on cost reductions and efficiencies has not yet translated into improved EBITDA, suggesting ongoing difficulties.
The long-term thesis hinges on the performance of sector bellwethers and HHS's ability to meet or exceed guidance in upcoming earnings calls. Any cuts to guidance could lead to negative sentiment, while positive momentum in the sector could provide support.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The acquisition by Star Equity enhances growth potential and customer relationships. This confirmed acquisition aligns with the company's growth strategy. There are no new threats impacting the thesis.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 2 of last 2 quarters. Revenue declined from $41.6M in 2025-Q1 to $37.3M in 2026-Q1 (-10.3%), with the company emphasizing alignment around priority sectors and building momentum toward positive EBITDA in 2026. The trajectory shows persistent focus but revenue pressure remains, indicating mixed delivery.
“We continued aligning Harte Hanks around priority sectors... positioned to execute on its growth strategy and build momentum toward positive EBITDA throughout 2026.”
“Our goal in 2026 is to deepen our customer relationships to drive profitable growth and long-term value for shareholders.”
Breaks if: net income and free cash flow remain negative beyond next 4 quarters
Breaks if: revenue growth falls below -5% next 4 quarters
Focus on aligning around priority sectors and combining customer experience expertise with technology to drive profitable growth.
Stated as a priority in 2 of last 2 quarters. Revenue declined from $41.6M in 2025-Q1 to $37.3M in 2026-Q1 (-10.3%), with the company emphasizing alignment around priority sectors and building momentum toward positive EBITDA in 2026. The trajectory shows persistent focus but revenue pressure remains, indicating mixed delivery.
“We continued aligning Harte Hanks around priority sectors... positioned to execute on its growth strategy and build momentum toward positive EBITDA throughout 2026.”
“Our goal in 2026 is to deepen our customer relationships to drive profitable growth and long-term value for shareholders.”
In the next 1 to 3 years, HHS must navigate significant challenges to improve its financial standing and operational performance. Not investment advice.